Cargando…
Immune system-associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most malignant types of cancer, and is associated with high recurrence rates and a poor response to chemotherapy. Immune signatures in the microenvironment of HCC have not been well explored systematically. The aim of the present study was to identify pro...
Autores principales: | Huang, Rongfu, Chen, Zheng, Li, Wenli, Fan, Chunmei, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115743/ https://www.ncbi.nlm.nih.gov/pubmed/32319580 http://dx.doi.org/10.3892/ijo.2020.4998 |
Ejemplares similares
-
m(6)A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2021) -
Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2021) -
EPRS1 correlates with malignant progression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2023) -
The immune contexture of hepatocellular carcinoma predicts clinical outcome
por: Foerster, Friedrich, et al.
Publicado: (2018) -
Coagulation factor VII and malignant progression of hepatocellular carcinoma
por: Chen, K-D, et al.
Publicado: (2016)